Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering ta… Read more
Syra Health Corp. Class A Common Stock (SYRA) - Total Liabilities
Latest total liabilities as of September 2025: $1.05 Million USD
Based on the latest financial reports, Syra Health Corp. Class A Common Stock (SYRA) has total liabilities worth $1.05 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Syra Health Corp. Class A Common Stock - Total Liabilities Trend (2020–2024)
This chart illustrates how Syra Health Corp. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Syra Health Corp. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Syra Health Corp. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CF INDUSTRIES HLDG - Dusseldorf Stock Exchang
DU:C4F
|
Germany | €6.11 Billion |
|
Panther Metals Ltd
AU:PNT
|
Australia | AU$111.06K |
|
Spectra7 Microsystems Inc
OTCQB:SPVNF
|
USA | $1.29 Million |
|
Stamper Oil & Gas Corp
PINK:STMGF
|
USA | $9.81 Million |
|
Shree Ram Proteins Limited
NSE:SRPL
|
India | ₹536.12 Million |
|
Apogee Minerals Ltd
V:APMI
|
Canada | CA$156.54K |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
USA | $7.42 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Syra Health Corp. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syra Health Corp. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syra Health Corp. Class A Common Stock (2020–2024)
The table below shows the annual total liabilities of Syra Health Corp. Class A Common Stock from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $800.76K | -12.01% |
| 2023-12-31 | $910.07K | -43.46% |
| 2022-12-31 | $1.61 Million | +195.85% |
| 2021-12-31 | $544.04K | +7490.85% |
| 2020-12-31 | $7.17K | -- |